Data-Driven Drug Discovery
The drug discovery industry is facing a productivity crisis with new approvals taking longer and costing more. In addition, discovery of treatments for complex diseases of aging are proving intractable. I will discuss the novel, computational approach to early drug discovery pioneered at e-therapeutics that aims to address some of these issues, along with the software platform enabling that discovery process.
Head of Discovery Informaticsat
Computational biologist with a unique background in drug discovery informatics, data science, complex system analysis, and software and data engineering. Proven architect and implementer of green-field computational solutions to complex problems. Builder and facilitator of cross-disciplinary scientific teams. Driven to create novel solutions for the improvement of human health.